C71T
CANCELLED SECTION 71
03/07/2026
Voltar para busca
Dado oficial do USPTO
CAELUS HEALTH
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
45
Atualização mais recente
28/07/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 10
Data de depósito
22/09/2016
Data de registro
17/12/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
03/07/2026
Última transação
28/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
26
Localização do titular
NL
Examinador
CORWIN, KEVIN SCOTT
Unidade examinadora
M30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Caelus Pharmaceuticals B.V.
Representantes
R. Glenn Schroeder Schroeder Law PC
Classificação técnica
Classes Nice
Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for treating cardiometabolic disorders; dietetic foodstuffs adapted for medical use and dietetic substancesdietetic foods adapted for medical use; food supplements for human beings; medical preparations and articles for the treatment of cardiometabolic disorders; pharmaceutical products and natural medicinesboth for the treatment of cardiometabolic disorders; pharmaceutical preparationsmedicinesfor the prevention of diabetes mellitusCrohn's disease and ulcerative colitis disease; pharmaceutical preparationsmedicines for the treatment of diabetes mellitusCrohn's diseaseulcerative colitis disease and metabolic syndrome being insulin resistance; dietetic nutritional food additives for medical purposes in the nature of natural food extracts derived from gut-microbiota and dietetic preparationsdietary supplements; dietary food preparationsdietetic nutritional food additives for medical purposes in the nature of natural food extracts derived from gut-microbiota and dietetic substances in the nature of dietary supplements for the prevention of diabetes mellitusCrohn's disease and ulcerative colitis disease; dietary food preparationsdietetic nutritional food additives for medical purposes in the nature of natural food extracts derived from gut-microbiota and dietetic substances in the nature of dietary supplements for the treatment of diabetes mellitusCrohn's diseaseulcerative colitis disease and metabolic syndrome being insulin resistance; preparationscultures of microorganisms for medical useincluding bacterial preparations
Classe 10
Medical diagnostictesting and monitoring equipmentblood testing apparatus for measuring insulin levels and Advanced Glycation Endproducts; medical test kits for home monitoring of diabetes
Publicações
Histórico de despachos e eventos da marca no USPTO.
45 publicações encontradas
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
17/12/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
30/12/2023
GPNX
NOTIFICATION PROCESSED BY IB
01/05/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/05/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
31/03/2020
FIMP
FINAL DISPOSITION PROCESSED
30/03/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
17/03/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
17/12/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/10/2019
PUBO
PUBLISHED FOR OPPOSITION
01/10/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/09/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/09/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/09/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
23/08/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/08/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/08/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
22/08/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
08/07/2019
GNFR
FINAL REFUSAL E-MAILED
08/07/2019
CNFR
FINAL REFUSAL WRITTEN
08/07/2019
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
14/12/2018
DOCK
ASSIGNED TO EXAMINER
12/12/2018
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
06/10/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
19/09/2018
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
19/09/2018
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
14/06/2018
NREP
NEW REPRESENTATIVE AT IB RECEIVED
15/12/2017
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/12/2017
GNSL
LETTER OF SUSPENSION E-MAILED
10/12/2017
CNSL
SUSPENSION LETTER WRITTEN
10/12/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/11/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/11/2017
ALIE
ASSIGNED TO LIE
03/11/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
24/10/2017
RFNT
REFUSAL PROCESSED BY IB
13/05/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
24/04/2017
RFRR
REFUSAL PROCESSED BY MPU
24/04/2017
MAFR
APPLICATION FILING RECEIPT MAILED
21/04/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
20/04/2017
CNRT
NON-FINAL ACTION WRITTEN
19/04/2017
DOCK
ASSIGNED TO EXAMINER
17/04/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/04/2017
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
14/04/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
13/04/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CAELUS HEALTH ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.